Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Reinhardt

Showing results (161-170 of 223) with videos related to

Pageof 23
Sort By:
Blood|July 2, 2010
High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicineCosta Bachas, Gerrit Jan Schuurhuis, Iris H I M Hollink, et al.
Haematologica|July 28, 2022
Analysis of rare driving events in pediatric acute myeloid leukemiaSanne Noort, Jolieke van Oosterwijk, Jing Ma, et al.
Blood|January 28, 2009
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemiaIris H I M Hollink, Marry M van den Heuvel-Eibrink, Martin Zimmermann, et al.
Haematologica|May 19, 2018
Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB studyNatasha K A van Eijkelenburg, Mareike Rasche, Essam Ghazaly, et al.
Bone Marrow Transplantation|November 5, 2023
Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trialKarl-Walter Sykora, Rita Beier, Ansgar Schulz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2013
Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study GroupGertjan J L Kaspers, Martin Zimmermann, Dirk Reinhardt, et al.
Blood|July 13, 2012
High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemiaMaaike Luesink, Iris H I M Hollink, Vincent H J van der Velden, et al.
Annals of Hematology|June 10, 2017
Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapyOussama Abla, Raul C Ribeiro, Anna Maria Testi, et al.
Nature Communications|August 11, 2017
The non-coding RNA landscape of human hematopoiesis and leukemiaAdrian Schwarzer, Stephan Emmrich, Franziska Schmidt, et al.
Cell Genomics|September 18, 2023
Comprehensive single-cell genome analysis at nucleotide resolution using the PTA Analysis ToolboxSjors Middelkamp, Freek Manders, Flavia Peci, et al.
Pageof 23

Showing results (161-170 of 223) with videos related to

Sort By:
Pageof 23
Blood|July 2, 2010
High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicineCosta Bachas, Gerrit Jan Schuurhuis, Iris H I M Hollink, et al.
Haematologica|July 28, 2022
Analysis of rare driving events in pediatric acute myeloid leukemiaSanne Noort, Jolieke van Oosterwijk, Jing Ma, et al.
Blood|January 28, 2009
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemiaIris H I M Hollink, Marry M van den Heuvel-Eibrink, Martin Zimmermann, et al.
Haematologica|May 19, 2018
Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB studyNatasha K A van Eijkelenburg, Mareike Rasche, Essam Ghazaly, et al.
Bone Marrow Transplantation|November 5, 2023
Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trialKarl-Walter Sykora, Rita Beier, Ansgar Schulz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2013
Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study GroupGertjan J L Kaspers, Martin Zimmermann, Dirk Reinhardt, et al.
Blood|July 13, 2012
High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemiaMaaike Luesink, Iris H I M Hollink, Vincent H J van der Velden, et al.
Annals of Hematology|June 10, 2017
Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapyOussama Abla, Raul C Ribeiro, Anna Maria Testi, et al.
Nature Communications|August 11, 2017
The non-coding RNA landscape of human hematopoiesis and leukemiaAdrian Schwarzer, Stephan Emmrich, Franziska Schmidt, et al.
Cell Genomics|September 18, 2023
Comprehensive single-cell genome analysis at nucleotide resolution using the PTA Analysis ToolboxSjors Middelkamp, Freek Manders, Flavia Peci, et al.
Pageof 23